Illumina announced the appointment of Eric Green, former director of the National Human Genome Research Institute, as chief medical officer effective February 2. Green will lead Illumina’s clinical strategy as the company pushes to expand genomic testing and integrate multiomic data into routine care. Green brings long experience in genomic policy and translational research; he said the role aligns with his interest in advocating for genomics in clinical practice. Illumina cited the hire as part of a broader push to lean into clinical markets and partner with health systems on comprehensive genomic profiling.